Article

Pharmacy Week in Review: September 9, 2016

Related Videos
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Illustration of opioid pills spilling out of pill bottle | Image Credit: © Nats - stock.adobe.com
May 21st 2025

Managing Opioid Complexity: The Role of Pharmacists in OUD and C-POD Care

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Young woman with cardiovascular disease -- Image credit: eddows | stock.adobe.com
May 21st 2025

Study Finds Increased Risk of CVD Among Women With History of Infertilty

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Prostate disease and treatment. Male reproductive system anatomical model in doctors hands close-up during consultation of male patient with suspected bacterial prostatitis - Image credit: Peakstock | stock.adobe.com
May 20th 2025

Anti-Diabetic Drug Could Offer New Treatment for Prostate Cancer

Kennedy Ferruggia, Assistant Editor
Doctor writes medical prescription for asthma inhaler to asthmatic patient during medical consultation and examination in hospital. Healthcare - Image credit: Goffkein | stock.adobe.com
May 20th 2025

Triple-Combination Therapy Met Primary End Point in Phase 3 Trials, Providing Treatment for Individuals With Asthma

Kennedy Ferruggia, Assistant Editor